Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Chronic thromboembolic pulmonary hypertension (CTEPH) is the result of clot persistence and fibrosis in the pulmonary vasculature after acute pulmonary embolism. This condition leads to elevated pulmonary pressures and eventually right heart failure. Patients are often severely limited by exertional dyspnea and can experience significant morbidity and mortality when left untreated. The condition is also associated with impairment of left ventricular diastolic function and filling. Pulmonary thromboendarterectomy (PTE) is currently the only curative treatment for CTEPH and greatly alters the clinical course of the disease.
Update in Echocardiography: Chronic Thromboembolic Pulmonary Hypertension
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi